Company Seeks To Test Stem Cells For Blindness | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Friday, November 20, 2009

Email

Comments

Reuters

Advanced Cell Technology, a small Massachusetts-based biotechnology company, said on Thursday it has asked for approval to test human embryonic stem cells in treating a rare cause of blindness.

The photograph below depicts:
1. A punctum occluded by an intracanalicular collagen plug
2. A punctum occluded by a silicone punctal plug
3. A punctum occluded by punctal cautery
4. A punctum occluded by an extruding Jones tube
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us